Authors


Mark T. Burger, PharmD

Latest:

15 keys to the New Pharmacy

In Part 3 of "The New Pharmacy," Mark Burger takes you through the daily checklist of a successful practice.


Richard Mark Kirkner

Latest:

The market side of biosimilars

R&D and product manufacture are only the beginning. When the time comes to enter the marketplace, biosimilars still face numerous obstacles.




Lauren J. VanHook, PharmD

Latest:

FDA approves PAH treatment

Selexipag is a first-in-class oral treatment option to reduce progression and hospitalization for pulmonary arterial hypertension.


Christian Hartman, PharmD, MBA, FSMSO

Latest:

Sterile compounding: Regulations, best practices, and industry standards

Where things stand, where they're headed, and what you need to do now.


Robert J. Stout, RPh

Latest:

“Pharmacists, lobby your legislators!” says BOP insider

If you want improved working conditions in the pharmacy, you're gonna hafta help.





Lauren Heroux-Camirand

Latest:

How pharmacists should be fighting the heroin epidemic

Once we as individuals in the healthcare profession finally begin to accept addiction as a disease and not a moral failing, the affected individuals will have a better chance at recovery and we will gain a better understanding of this epidemic.



Liz Meszaros

Latest:

Pharmacy of tomorrow

Tomorrow's pharmacists and pharmacies will need to find ways to increase profit margins by reducing the cost of prescribing, embracing technology, and focusing more on patient counseling, immunizations, education, and other offshoots of their clinical expertise.





Heide Aungst

Latest:

Niche pharmacies serve children and the elderly

Specialty pharmacies are developing to meet the growing needs of children and senior citizens.


Jill Wechsler

Latest:

User Fees Reauthorized for FDA

FDA keeps its user fees but fails to gain important reforms.


Julia Talsma, Editor-in-Chief

Latest:

Drug Topics CPE accreditor begins 3-year service to AACP

During the American Association of Colleges of Pharmacy (AACP) Annual Meeting in Kissimmee, Fla. in mid-July, Jill Fitzgerald, PharmD, who is Drug Topics CPE accreditor, was sworn in as chair-elect to the AACP Continuing Professional Education Section.



Drug Topics readers

Latest:

Letters

Readers have their say on unionization, fair reimbursement, and self-regulation.



Leah Perry

Latest:

Pipeline drugs 2010

Categories to watch in this year's diverse drug pipeline include oral agents to treat multiple sclerosis and a host of new diabetes, cardiovascular, and pain-management products.


David D. Trang, PharmD, MBA

Latest:

Is the pharmacist shortage over?

Increasing enrollment in pharmacy schools and changing economic factors appear to have eased the national pharmacist shortage. In order to plan appropriately for all stakeholders, we need to quantify the numbers when we talk about a pharmacist shortage.


Ernest P. Gates Jr., RPh, FASCP, FIACP, FACA

Latest:

Opinion: Compounding Pharmacists Must Rebuild the Industry

Four steps that compounding pharmacists must take to restore their credibility.


Michael J. Schuh, BS, PharmD, MBA

Latest:

A retail pharmacist examines the consequences of working in a fishbowl

Doctors don't do it. Attorneys don't do it. Physical therapists, insurance agents, title agents, audiologist, and nurse practitioners don't do it. Who came up with the fishbowl model of retail pharmacy anyway?


Ken Krizner

Latest:

Top Challenges in Managing Diabetes

Cost, education, self-monitoring, and more. 


Christine Blank

Latest:

Continuous Glucose Monitors Useful for Predicting Pre-Diabetes

When employed as a prescreening tool, care must be taken to avoid overdiagnosis of healthy individuals without diabetes.


Ron Rajecki

Latest:

Drug Topics' 2010 business outlook survey

Respondents to this year's business outlook survey are generally upbeat about the business their pharmacies are doing and their prospects for the coming year.


From staff reports

Latest:

FDA warns against prolonged use of magnesium sulfate to stop preterm labor

FDA advised healthcare professionals not to use magnesium sulfate injection for more than 5-7 days to stop preterm labor in pregnant women.

© 2025 MJH Life Sciences

All rights reserved.